News

Isoplexis IsoLight Automated Celluar Proteomic in CCP

08. 08. 2022 Information News PR Service

We would like to inform our users that CCP now offers automated single cell functional proteomics analysis on the Isoplexis platform enabling for single cell functional immunophenotyping or phospho-protein analysis. If you want to know more about the device and services available in CCP for your research please check the details at our immunology unit…

We are searching new colleagues!

25. 07. 2022 Information Jobs

A new positions of a PDX Model / Veterinary Specialist(s) and Histology Lab Technician are available in the CCP. For more details go to our Career page.

A delegation of EU member states, representatives of the Council of the EU and the Ministry of Education,Youth and Sports visited the research infrastructures at the BIOCEV center

22. 07. 2022 Information News PR

On July 21, 2022, a delegation of representatives of the Council of the EU and the Ministry of Education, Youth and Sports visited the BIOCEV, a joint centre of the Czech Academy of Sciences and Charles University in Vestec near Prague. The goal was to present large research infrastructures and their potential for collaboration in…

AV21 Centre for Preclinical Testing: The path form the test tube to the patients

15. 07. 2022 Information News PR Service

To test substances that have succeeded in basic research and help them on the long journey from the test tube to the development of new drugs. This is the goal of the Centre for Preclinical Testing, funded by the Strategy of the Czech Academy of Sciences AV21. The centre is run in close collaboration of…

Isidore Information Webinar

24. 06. 2022 Event

12 July 2022, Online / 10AM-11:30AM CEST The ISIDORe consortium has recently launched its first call to support research on SARS-CoV-2 and COVID-19. It provides free of charge access to more than 300 services from ISIDORe’s integrated portfolio of cutting-edge research services dedicated to epidemic-prone disease research. It will follow in coming weeks with a…

Global and European Infrastructures IMPC and INFRAFRONTIER Towards the Deciphering of Gene Functions for Human Health

21. 06. 2022 Event

18 October 2022, Brno, Czech Republic / Satellite event of the ICRI Conference The satellite event aims to showcase the scientific achievements and impact on various areas of human disease research and share its experience of the management of the scientific data produced, and describe how IMPC and INFRAFRONTIER with their resources and technologies strive…

First call to access the ISIDORe resources dedicated to SARS-CoV-2 and COVID-19

10. 06. 2022 Call News Service

The first call is divided into six main sections which are: Surveillance & Epidemic Risk Management; Understanding SARS-CoV-2 & Covid-19; Diagnostics; Therapeutics; Vaccines; and Social Sciences & Epidemiology. The call is multidisciplinary and open to all scientists both from academia and private sector, including the partners of the ISIDORe consortium. The users wishing to benefit…

International Congress of Research on Rare and Orphan Diseases – RE(ACT) Congress and IRDiRC Conference

27. 05. 2022 Event

15 – 18 March 2023, Berlin, Germany / This joint event continues the IRDiRC Conference series (5th edition) and the RE(ACT) Congress series (7th edition). It aims to bring together scientific leaders, experts, and young scientists from various breakthrough scientific fields to present cutting-edge research, exchange ideas, and discuss policies related to rare diseases research.…

INFRAFRONTIER Seminar: Recent Advances in Human Disease Modeling

27. 05. 2022 Event

1 June 2022, Oulu, Finland / The hybrid event gathers European INFRAFRONTIER partners together to present their recent achievements in biomedicine and technological advances in modeling human diseases. More information: University of Oulu

Gene therapy of rare diseases – opportunity for prospective PhD students

11. 05. 2022 Uncategorized

Czech Centre for Phenogenomics is a member of the consortium gathered in the new Marie Skłodowska-Curie Action Doctoral Network focused on gene therapy of rare diseases. The project, coordinated by the University of Copenhagen, was approved by the European Commission in April and will start in September 2022. This project is a unique opportunity for…

1 2 3 17